NCT05661136

Brief Summary

It is unclear whether routine addition of intra-operative forced-air warming in addition to warmed intravenous fluids during cesarean delivery under spinal anesthesia is beneficial. In this single-center randomized trial, we aim to test the primary null hypothesis that our current protocol of warmed intravenous fluids is similar to a combination of warmed intravenous fluids with intra-operative lower-body forced-air warming to maintain maternal temperature after cesarean delivery under spinal anesthesia. We also aim to assess the rate of maternal shivering during and after the procedure between the two groups, the maternal thermal comfort score, neonatal Apgar scores and umbilical pH levels. If we demonstrate no clinically important difference between the two interventions, clinicians will be able to continue our current protocol of warmed intravenous fluids only during cesarean delivery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 6, 2022

Completed
7 days until next milestone

Study Start

First participant enrolled

December 13, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 22, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 8, 2023

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 9, 2023

Completed
Last Updated

February 14, 2025

Status Verified

February 1, 2025

Enrollment Period

3 months

First QC Date

December 6, 2022

Last Update Submit

February 12, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • The mean core temperature

    The primary aim is the mean core temperature on arrival to PACU. The means for the two groups will be compared.

    baseline, immediately before spinal anesthesia, 60 minutes following spinal anesthesia and then every 30 minutes for 2 hours (last measurement prior to discharge)

Secondary Outcomes (7)

  • Maternal hypothermia

    60 minutes following spinal anesthesia

  • Shivering

    Postoperative - every 30 minutes for 2 hours (last measurement prior to discharge)

  • Maternal thermal comfort

    baseline, immediately before spinal anesthesia , 60 minutes following spinal anesthesia, and then every 30 minutes for 2 hours (last measurement prior to discharge)

  • Meperidine

    Postoperative - up to two hours during PACU recovery after the procedure

  • Apgar

    1 and 5 minutes after newborn delivery

  • +2 more secondary outcomes

Study Arms (2)

Warm air blower

EXPERIMENTAL

Intra-operative lower-body forced-air warming after spinal anesthesia and co-loading 1000 mL liters of IV warmed-fluids started prior to performing spinal anesthesia

Device: Warm air blower

Control

ACTIVE COMPARATOR

Co-loading of 1000 mL liters of IV warmed-fluids started prior to performing spinal anesthesia

Other: Control: Lower body blanket not attached to warm air blower

Interventions

Lower body blanket with warm air blower set at 44 deg c started after spinal anesthesia when patient placed in supine/left lat position

Warm air blower

Control: Lower body blanket placed, not attached to warm air blower

Control

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Written informed consent
  • Age between 18-50 years old
  • American Society of Anesthesiologists (ASA) physical status 2-3
  • Gestational age greater than 37 completed weeks
  • Singleton pregnancy
  • Elective cesarean delivery.

You may not qualify if:

  • Known allergy to local anesthetics
  • Contraindication for spinal anesthesia
  • Patient refusal
  • Bleeding diathesis
  • Neuropathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tel Aviv SMO

Tel Aviv, Israel

Location

MeSH Terms

Conditions

Body Temperature Changes

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Postanesthesia care unit nurses assess primary outcome and will not know the group assignment Sample size was calculated for the primary outcome of difference between the groups in maternal temperature on arrival to the post-anesthesia care unit. We calculated the a priori sample size, WinPepi, based upon a prior publication that compared Active-Warming versus No-Warming, mean(standard deviation) 35.9(0.5)0 C versus 35.5(0.5), power 90%, 0.05 two-sided significance (Cobb et al). For clinical significance we calculated sample size with a mean difference of 0.50 C, with SD 0.5, power 90%, two sided significance with potential for 10% dropouts, total 66 women, 33 per group, and without dropouts, 22 per group total 44 women.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: two arms: lower body forced air warming versus none
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 6, 2022

First Posted

December 22, 2022

Study Start

December 13, 2022

Primary Completion

March 8, 2023

Study Completion

March 9, 2023

Last Updated

February 14, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

no plan

Locations